Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...
Researchers continue to look for new ways of diagnosing Alzheimer’s disease early — a type of dementia currently affecting about 32 million people worldwide. “Alzheimer’s disease is diagnosed up to 20 ...
ST. LOUIS--(BUSINESS WIRE)--People in Canada concerned about their memory loss or their loved ones’ issues now have a new option to aid in diagnosis. Toronto Memory Program (TMP) is the first clinic ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results